Another thing that makes Ozempic dangerous is that it can cause a persons stomach muscles to stop contracting altogether
This efficacy suggests the drug could be suitable for patients with greater weight loss needs, including as an alternative to more invasive treatments like bariatric surgery
Therefore, drugs that target these mechanisms, such as GLP-1 RAs, might have beneficial effects in both diseases. Daniel Truong, MD In some studies, the prevalence of Parkinsons disease was lower among patients with diabetes who were treated with glucagon-like peptide-1 (GLP-1) receptor agonists or dipeptidyl peptidase-4 inhibitors, which increase GLP-1 levels, than among patients who received other diabetes medications, Truong said
The table shows that resmetirom is a small (molecular weight about 600 g/mol), non-iodinated THR- agonist administered once daily as an oral tablet, while semaglutide is a large (about 4 kDa) GLP-1 peptide designed for once-weekly subcutaneous injection or, with SNAC enhancement, once-daily oral administration